Protection of estrogens against the progression of chronic liver disease.
about
Advances in non-surgical management of primary liver cancer.Prior to the oral therapy, what do we know about HCV-4 in Egypt: a randomized survey of prevalence and risks using data mining computed analysis.Comedications alter drug-induced liver injury reporting frequency: Data mining in the WHO VigiBase™.17,β-estradiol inhibits hepatitis C virus mainly by interference with the release phase of its life cycleOral contraceptive pill use is associated with reduced odds of nonalcoholic fatty liver disease in menstruating women: results from NHANES IIIEstrogen receptor alpha gene polymorphisms and risk of HBV-related acute liver failure in the Chinese populationEstrogen receptor alpha expression and liver fibrosis in chronic hepatitis C virus genotype 1b: a clinicopathological studyFemale hepatology: favorable role of estrogen in chronic liver disease with hepatitis B virus infection.Body mass index is associated with age-at-onset of HCV-infected hepatocellular carcinoma patients.Reproductive factors, exogenous hormone use and risk of hepatocellular carcinoma among US women: results from the Liver Cancer Pooling ProjectEstradiol modulates membrane-linked ATPases, antioxidant enzymes, membrane fluidity, lipid peroxidation, and lipofuscin in aged rat liver.Non-alcoholic steatohepatitis-related liver cirrhosis is increasing in China: a ten-year retrospective study.In vitro and in vivo effects of ethanol extract combined with Curcumae Radix and Glycyrrhizae Radix et Rhizoma on menopausal metabolic disturbances.Role of estrogen receptor β selective agonist in ameliorating portal hypertension in rats with CCl4-induced liver cirrhosisEffects of estradiol and progesterone on the proinflammatory cytokine production by mononuclear cells from patients with chronic hepatitis CRole of sex steroid receptors in pathobiology of hepatocellular carcinoma.Role of estrogen in liver cancer.Disease progression in Chinese patients with hepatitis C virus RNA-positive infection via blood transfusion.Downregulation of sulfotransferase expression and activity in diseased human livers.Protein inhibitor of activated STAT 4 (PIAS4) regulates pro-inflammatory transcription in hepatocytes by repressing SIRT1.Males develop faster and more severe hepatocellular carcinoma than females in krasV12 transgenic zebrafish.Nonalcoholic fatty liver disease and metabolic syndrome in postmenopausal women.Brahma-related gene 1 bridges epigenetic regulation of proinflammatory cytokine production to steatohepatitis in mice.MicroRNA-19b reduces hepatic stellate cell proliferation by targeting GRB2 in hepatic fibrosis models in vivo and in vitro as part of the inhibitory effect of estradiol.The role played by gender in viral hepatitis.Polymorphism of estrogen receptor alpha (ESR1) is associated with virological response to entecavir (ETV) in nucleoside-naïve adult patients with chronic hepatitis B.Normal enhanced liver fibrosis (ELF) values in apparently healthy subjects undergoing a health check-up and in living liver donors in South Korea.A cis-acting regulatory variation of the estrogen receptor α (ESR1) gene is associated with hepatitis B virus-related liver cirrhosis.The pro-fibrotic effects of pregnancy in a carbon-tetrachloride-induced liver injury in mouse model.A biomarker panel for non-alcoholic steatohepatitis (NASH) and NASH-related fibrosis.Waist circumference correlates with hepatic fat accumulation in male Japanese patients with non-alcoholic fatty liver disease, but not in females.Exemestane Attenuates Hepatic Fibrosis in Rats by Inhibiting Activation of Hepatic Stellate Cells and Promoting the Secretion of Interleukin 10.A case of synthetic oestrogen-induced autoimmune hepatitis with microvesicular steatosis.Raloxifene Ameliorates Liver Fibrosis of Nonalcoholic Steatohepatitis Induced by Choline-Deficient High-Fat Diet in Ovariectomized Mice.Estrogen suppresses heptatic IκB expression during short-term alcohol exposure.Estrogen suppresses metastasis in rat hepatocellular carcinoma through decreasing interleukin-6 and hepatocyte growth factor expression.An intracrine view of sex steroids, immunity, and metabolic regulation.Catalase and estradiol inhibit mitochondrial protein S-glutathionylation."Normal" liver stiffness values differ between men and women: a prospective study for healthy living liver and kidney donors in a native Korean population.
P2860
Q30423781-0C3D78C4-F114-466B-AF9C-DFB72853A660Q30881190-798040A5-3290-4DA4-9E81-6276EF07C7F4Q30954151-A3DD7C22-98C2-45B0-B759-86E005B147E6Q33737534-59CB23BB-61AB-4808-95F8-5FC021685D27Q34223422-62A50DD2-9775-4238-8560-DCFCE37F5BA4Q34315221-4826FBBB-D39B-49E3-8518-329557EA7C14Q34426007-D92878F4-E105-41D4-AF19-E278DC6ADC31Q34606036-13FDED92-6256-4CF1-A9BF-48021213A9F3Q34635064-A1077CC8-BEDE-41F2-9117-D875962BA4EBQ35274912-7F5F95DF-6783-423E-9F1D-84F5DCFC47F3Q35325434-A6305845-6EF1-48EA-92BF-9BDFB23DA4ADQ35899644-2735283C-A872-4FFF-B366-97FBA2148353Q36317419-9CC95118-11BF-4E47-A590-37607DC28436Q36875004-345F2154-FFA7-4E4B-ADAB-4C1FA2BC693CQ37245488-43F85791-31EE-4DCE-8AC0-886230672A66Q37302943-FABD8C0A-F5E9-4F7F-9596-5AC64F618732Q37346076-AA41378B-5563-4F43-ADB2-2AD5E6FDC016Q37406708-E4F6F849-A4C8-49E0-A76B-A880C1E0A625Q37422741-4ECBC23F-C75F-4E1B-9D58-53C9775331AAQ37536430-8E6FDCC0-4B04-4883-AD27-0DAA2F471E6FQ37602180-48423FF2-7BB9-4FE2-A025-A7C9A5E6EC25Q38181562-ABC408D2-E482-4BA4-B12E-5C026AF672AEQ39217887-E9AD18D2-A8CA-4F5B-AD24-545BEFD9B1AFQ41504596-C57950F5-1E8D-470F-880F-1807DAECD8C5Q42202432-FED5703B-C505-4ACF-A6C0-83A19EB02CC3Q42288459-FEB908E2-FFE5-49F4-9D8D-AFE7C672F3E4Q44663535-D6F02C98-6D67-4706-A0EC-64114542F680Q45364189-5CC17CEB-8D32-4BC9-A9AE-8C2115DF984EQ46056717-6B2866F3-36D2-4B78-88F1-255AA994E26EQ46177222-B9CB6D8C-3528-4C40-81B1-4FEAF2951FEAQ46676500-6A4A9746-220F-457C-AF5A-02A404A0627CQ49724206-9BC00425-4559-49D0-9CC9-DDD87DC57AE7Q50467024-5A160DC1-51FA-4FC8-B0E2-A75BCD73380BQ51034522-E81A4A1C-3E8D-4F2D-84A1-3E3AB825F6E0Q51334134-DA3D44EC-17AA-477A-AE08-A5FF5F74B324Q51507148-B7F014AB-4883-448E-B42D-ACA488525DA1Q52650003-C2E6B8B6-CA67-4CB5-831F-7FF682785EAFQ53165065-DFA5077F-DEB7-446F-A53C-310EE21D3A34Q53398091-A68D5605-D716-4E36-99C8-A62DB71C8777
P2860
Protection of estrogens against the progression of chronic liver disease.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Protection of estrogens against the progression of chronic liver disease.
@en
Protection of estrogens against the progression of chronic liver disease.
@nl
type
label
Protection of estrogens against the progression of chronic liver disease.
@en
Protection of estrogens against the progression of chronic liver disease.
@nl
prefLabel
Protection of estrogens against the progression of chronic liver disease.
@en
Protection of estrogens against the progression of chronic liver disease.
@nl
P2860
P1433
P1476
Protection of estrogens against the progression of chronic liver disease.
@en
P2093
Ichiro Shimizu
Susumu Ito
P2860
P304
P356
10.1111/J.1872-034X.2007.00032.X
P577
2007-04-01T00:00:00Z